Trypsin-Protease Activated Receptor-2 Signaling Contributes to Pancreatic Cancer Pain

Oncotarget - United States
doi 10.18632/oncotarget.18696
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Erratum To: Protease-Activated-Receptor-2 Affects Protease-Activated-Receptor-1-Driven Breast Cancer

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2016English

Protease-Activated Receptor 2 (PAR2)

Science-Business eXchange
2012English

A Polymorphic Protease-Activated Receptor 2 (PAR2) Displaying Reduced Sensitivity to Trypsin and Differential Responses to PAR Agonists

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2017English

Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation

Cardiology
Cardiovascular MedicinePharmacologyCardiology
2016English

Pancreatic Trypsin Inhibitor. 2. Reaction With Trypsin

Biochemical Journal
1953English

Calcium Dependence of Protease-Activated Receptor 2 and Cholecystokinin Mediated Amylase Secretion From Pancreatic Acini

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2005English

Termination of Signaling by Protease-Activated Receptor-1 Is Linked to Lysosomal Sorting

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Acanthamoeba Protease Activity Promotes Allergic Airway Inflammation via Protease-Activated Receptor 2

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy